Obesity associated with diabetes mellitus is a significant worldwide problem associated with considerable health care costs. Whilst surgical intervention is effective, it is invasive, costly and associated with complications. This study aims to evaluate the safety and efficacy of the EndoBarrier®, a duodenal-jejunal sleeve bypass as an alternative treatment of diabetes mellitus in obese patients.
GI Dynamics Announces Agreement with Apollo Sugar to Study EndoBarrier in IndiaTrial to focus on reduction of hemoglobin A1c for patients diagnosed with type 2 diabetes and obesity. BOSTON, SYDNEY, HYDERABAD,...